EEP Advisers Mergers and Acquisitions Summary

Venture Capital Firm Profile

EEP Advisers’ most common sector for investment islife science (100%). The Firm’s most common investment types include venture (67%) and buyout (lbo, mbo, mbi) (34%). In total, EEP Advisers has invested in 2 different countries.

The Firm’s most common exit type is trade sale (80%). EEP Advisers’ largest (disclosed) exit occurred in 2016 when it sold AGC Biologics for $497M.

Join Mergr to view EEP Advisers’ full profile and discover more small venture capital firm investors just like it.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity3
    • M&A Sell Activity5
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 6

EEP Advisers

European Equity Partners

City Point 1 Ropemaker Street,
London, EC2Y 9HT
United Kingdom
+44 207 629 9992
www.eeplp.com
mail@eeplp.com

EEP is a Venture Capital investment firm that provides both dedication and passion on top of the financial investment itself. With more than 25 years of investment experience in life sciences, EEP provides deep sectorial knowledge and an established network. EEP was founded in 1999 and is based in London, England.


Investment Criteria

Sectors of Interest: Life Science

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Nordic

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
Sell (0.2/yr) # 4 1 - - - - 5
vol $497M $497M
  8

Most Recent M&A

Company Date Value Type
Azanta A/S 2020-03-24 - Trade Sale
Valby, Denmark · www.azanta.com
Bactolife A/S 2017-01-02 - Venture
Copenhagen, Denmark · www.bactolife.com
AGC Biologics 2016-12-20 497M JPY Trade Sale
Bothell, Washington · www.agcbio.com
Prenax SAS 2012-07-09 - Secondary Sale
Courbevoie, France · www.prenax.fr
AGC Biologics 2008-02-29 - Venture
Bothell, Washington · www.agcbio.com
Aster-Cephac SA 2006-01-05 - Trade Sale
Paris, France
PharmaKinetics Laboratories, Inc. 2002-01-01 - Trade Sale
Baltimore, Maryland
Aster-Cephac SA 1997-01-23 - Buyout (LBO, MBO, MBI)
Paris, France
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 1 (100%) - 3 (100%) -
Total 1 - 3 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
Denmark 1 (100%) - 2 (67%) -
  Washington - - 1 (33%) -
France - - 1 (33%) -
Total 1 - 3 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 1 (100%) - 2 (67%) -
Buyout (LBO, MBO, MBI) - - 1 (33%) -
Total 1 - 3 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 2 (40%) 497M (100%)
Trade Sale 2 (40%) -
Secondary Sale 1 (20%) -
Total 5 $497M

Deal Values

sell # Total
$100M to $1B 1 $497M
TOTAL $497M
Largest AGC Biologics
$497M (2016-12-20)

M&A Connections

Deals
Exited to
Investor(s)
20%
1 (20%)
Strategic(s)
80%
4 (80%)

Investor Summary

Investor Type

Venture Capital Firm

Size

Small

Established

1999

Specialist/Generalist

Specialist

Leadership

David Kauffmann

Founding Partner

Neil Boughton

Partner, CFO & COO

FAQ

When was EEP Advisers founded?

EEP Advisers was founded in 1999.

What type of investor is EEP Advisers?

EEP Advisers is a venture capital firm.

Where is EEP Advisers headquartered?

EEP Advisers is headquartered in London, United Kingdom.

 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal